Furthermore, given that CCL3 or its derivatives have been tried in humans to induce hematopoietic cell mobilization to peripheral blood, without severe adverse effects58,59, it may be a therapeutic strategy for an aneurysm. This evidence concerns the gene CCL3 and aneurysm.